Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
about
Progress and prospects in pharmacogenetics of antidepressant drugs.The PHF21B gene is associated with major depression and modulates the stress response.Single-nucleotide variant proportion in genes: a new concept to explore major depression based on DNA sequencing data.APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.A novel strategy for clustering major depression individuals using whole-genome sequencing variant dataA latent genetic subtype of major depression identified by whole-exome genotyping data in a Mexican-American cohort.Linkage and association analysis of ADHD endophenotypes in extended and multigenerational pedigrees from a genetic isolate.Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs.BDNF/TRKB/P75NTR polymorphisms and their consequences on antidepressant efficacy in depressed patients.The antidepressant fluoxetine acts on energy balance and leptin sensitivity via BDNF.Whole-genome single nucleotide variant distribution on genomic regions and its relationship to major depression.Molecular psychiatry: 20 years.Biological and behavioural antidepressant treatment responses with the selective serotonin reuptake inhibitor fluoxetine can be determined by the environment.Low-frequency and rare variants may contribute to elucidate the genetics of major depressive disorder.
P2860
Q30249569-3AA192B5-88A1-46F8-9FB2-452D6F008E3CQ30854997-B7486A46-9505-4383-B497-06F7B7EAEE6EQ31158801-12E5E6E5-BE4E-46B6-8A7A-37FDB723A8D6Q33629402-5134CE38-DE89-45D7-8F51-653EB17B8921Q36306020-3CDC0331-9700-41C9-9B54-58B5153979A3Q36373005-F2C57FD6-C0AB-43D7-88E1-F61689DD5702Q36932721-77BD5F0B-85E4-42A1-8947-D53031B33CFDQ37344778-B1A84568-B9EE-4851-816A-A06EC8B16945Q38540142-FEB5A6E6-A96F-4325-AF95-09E49313F576Q47833605-3761CE48-5776-4648-B806-E38E97314144Q47955566-73360A61-A090-4E71-BB78-D6D5D5DA3173Q48045630-A505262F-A582-4C95-BB78-EF56C0D4BFDBQ48250671-39C06695-1887-414F-8E48-A435240A1F8EQ52341028-81C03613-132D-4983-8266-C3F791023479
P2860
Clinical outcomes and genome-wide association for a brain methylation site in an antidepressant pharmacogenetics study in Mexican Americans.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical outcomes and genome-w ...... cs study in Mexican Americans.
@ast
Clinical outcomes and genome-w ...... cs study in Mexican Americans.
@en
Clinical outcomes and genome-w ...... cs study in Mexican Americans.
@nl
type
label
Clinical outcomes and genome-w ...... cs study in Mexican Americans.
@ast
Clinical outcomes and genome-w ...... cs study in Mexican Americans.
@en
Clinical outcomes and genome-w ...... cs study in Mexican Americans.
@nl
prefLabel
Clinical outcomes and genome-w ...... cs study in Mexican Americans.
@ast
Clinical outcomes and genome-w ...... cs study in Mexican Americans.
@en
Clinical outcomes and genome-w ...... cs study in Mexican Americans.
@nl
P2093
P2860
P1476
Clinical outcomes and genome-w ...... cs study in Mexican Americans.
@en
P2093
Chuanhui Dong
Deborah L Flores
Ma-Li Wong
Monika Ehrhart-Bornstein
Stefan Bornstein
P2860
P304
P356
10.1176/APPI.AJP.2014.12091165
P407
P577
2014-10-31T00:00:00Z